[go: up one dir, main page]

Colombo et al., 2017 - Google Patents

Binding of high mobility group A proteins to the mammalian genome occurs as a function of AT-content

Colombo et al., 2017

View HTML
Document ID
11804324803205640542
Author
Colombo D
Burger L
Baubec T
Schübeler D
Publication year
Publication venue
PLoS genetics

External Links

Snippet

Genomic location can inform on potential function and recruitment signals for chromatin- associated proteins. High mobility group (Hmg) proteins are of similar size as histones with Hmga1 and Hmga2 being particularly abundant in replicating normal tissues and in …
Continue reading at journals.plos.org (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6802—General aspects
    • C12Q1/6809—Sequence identification involving differential detection

Similar Documents

Publication Publication Date Title
Choi et al. Massively parallel reporter assays of melanoma risk variants identify MX2 as a gene promoting melanoma
Cuadrado et al. Specific contributions of cohesin-SA1 and cohesin-SA2 to TADs and polycomb domains in embryonic stem cells
Ramírez et al. High-resolution TADs reveal DNA sequences underlying genome organization in flies
Illingworth et al. Orphan CpG islands identify numerous conserved promoters in the mammalian genome
Zuin et al. A cohesin-independent role for NIPBL at promoters provides insights in CdLS
Domcke et al. Competition between DNA methylation and transcription factors determines binding of NRF1
Elliott et al. Intermediate DNA methylation is a conserved signature of genome regulation
Verfaillie et al. Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
Jägle et al. SNAIL1-mediated downregulation of FOXA proteins facilitates the inactivation of transcriptional enhancer elements at key epithelial genes in colorectal cancer cells
Hagarman et al. Coordinate regulation of DNA methylation and H3K27me3 in mouse embryonic stem cells
Yao et al. Functional annotation of colon cancer risk SNPs
Chamberlain et al. DNA methylation is developmentally regulated for genes essential for cardiogenesis
Hawkins et al. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells
Lake et al. RBPJ, the major transcriptional effector of Notch signaling, remains associated with chromatin throughout mitosis, suggesting a role in mitotic bookmarking
Colombo et al. Binding of high mobility group A proteins to the mammalian genome occurs as a function of AT-content
Gehre et al. Lysine 4 of histone H3. 3 is required for embryonic stem cell differentiation, histone enrichment at regulatory regions and transcription accuracy
Kramer et al. Developmental dynamics of X-chromosome dosage compensation by the DCC and H4K20me1 in C. elegans
Salama et al. Heterogeneous effects of direct hypoxia pathway activation in kidney cancer
Hosogane et al. Ras-induced changes in H3K27me3 occur after those in transcriptional activity
Jiang et al. Human transposons are an abundant supply of transcription factor binding sites and promoter activities in breast cancer cell lines
Chu et al. Genotranscriptomic meta‐analysis of the CHD family chromatin remodelers in human cancers–initial evidence of an oncogenic role for CHD 7
Lange et al. Non-coding variants in cancer: mechanistic insights and clinical potential for personalized medicine
Shi et al. De novo transcriptome sequencing to identify the sex-determination genes in Hyriopsis schlegelii
Zanzoni et al. Post-transcriptional regulatory patterns revealed by protein-RNA interactions
Cui et al. Comparative analyses of H3K4 and H3K27 trimethylations between the mouse cerebrum and testis